NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial | MicrobiomeTrials← Back to trialsNCT04750616
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2021-09-13Est. Completion: 2026-06-19
Enrollment target: 331 participants Locations- Kaiser Permanente San Francisco Medical Center, San Francisco, California, United States
Other microbiome trials you might be interested in
Out-of-Hospital Cardiac ArrestHypoxic-Ischemic Brain InjuryPost-Cardiac Arrest Syndrome
Most patients resuscitated from out-of-hospital cardiac arrest (OHCA) remain comatose on hospital admission and are rout…
Ljubljana, SloveniaEst. completion Sep 2028
Inhalation AnesthesiaDexmedetomidineSevofluraneLaparoscopy
Sevoflurane is a volatile agent easy to control thanks to the Minimum Alveolar Concentration (MAC) allowing its titratio…
Montreal, CanadaCompleted Nov 1, 2025